N4 Pharma (LON:N4P) Shares Up 23.8% – Here’s Why

N4 Pharma Plc (LON:N4P)’s stock price was up 23.8% during mid-day trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.65 ($0.01). Approximately 10,628,002 shares changed hands during trading, an increase of 331% from the average daily volume of 2,466,094 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Stock Up 23.8 %

The stock has a market cap of £2.57 million, a P/E ratio of -55.00 and a beta of -0.37. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The stock’s fifty day moving average price is GBX 0.62 and its 200 day moving average price is GBX 0.57.

N4 Pharma Company Profile

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.